|
⚲
|
| Keyboard |
| Doyle Janeen Noel
✚
|
|
|---|---|
| CIK # | 0002069239 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002069239] | |
| 4 | [0002069239] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Janux Therapeutics Inc | |
| Doyle Janeen Noel |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Janux Therapeutics Inc JANX
Common Stock
|
2026-01-02 | Grant | 36,000 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock option (right to buy) · derivative
|
2026-01-02 | Grant | 126,000 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2025-06-02 | Grant | 44,000 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock option (right to buy) · derivative
|
2025-06-02 | Grant | 154,000 | $0.00 |